AR and prostate carcinoma: The hypothesis has been supported by some recent studies indicating that androgen-refractory prostate cancer cells contain an apparent basal/stem cell-like signature [9-12], suggesting that these cancer cells may not be derived from the AR+ luminal cell population [9].